SourceBio International plc
(“SourceBio”, the ”Company” or ”the Group”)
Which? endorsement for day two travel PCR test
SourceBio International plc (AIM: SBI), a leading international provider of integrated state-of-the-art laboratory services and products, notes an online article published by Which? titled ‘The best cheap day two Covid tests for travel’ that recommends SourceBio as the best provider of day two travel COVID-19 PCR testing among a cohort of 50 companies supplying home testing kits, found on www.Gov.uk.
Which? is a non-for-profit organisation which provides impartial expert advice and recommendations to help consumers make better decisions. During the review, Which? applied various criteria to narrow the list of 50 companies down to 7 to investigate with a mystery shopper, a common practice used by retailers, market research and consumer watchdogs to measure the quality of customer service. Which? then shopped at each supplier 13 times to check how often the test kits and results arrived on time.
The mystery shop concluded that SourceBio’s travel COVID-19 PCR test was the most reliable of all providers, with test kits and results arriving on time on 12 out of 13 occasions. The endorsement from Which? is a significant achievement given the complete impartiality of the selection process and underlines the excellent customer service and affordability of the day two PCR testing service offering by the Group.
Jay LeCoque, Executive Chairman, commented: “We are delighted to be named by Which? as the best provider of affordable day two consumer travel PCR testing. Which? is a completely impartial organisation and their review process involved a comprehensive mystery shop process, highlighting SourceBio’s PCR testing service as the most reliable out of 50 businesses assessed. Outstanding customer service has always been central to SourceBio, and we will continue to maintain this standard as our customers trust us with their day two travel PCR testing.”
For further information please contact:
SourceBio International plc
www.sourcebiointernational.com
Jay LeCoque, Executive Chairman
Via Walbrook PR
Tony Ratcliffe, Chief Financial Officer Liberum (Nominated Adviser and Broker)
Tel: 020 3100 2000
Bidhi Bhoma Euan Brown William Hall Walbrook PR Limited
Tel: 020 7933 8780 or sourcebio@walbrookpr.com
Paul McManus / Sam Allen
Mob: 07980 541 893 / 07748 651 727
About SourceBio International plc www.sourcebiointernational.com
SourceBio is a leading international provider of integrated state-of-the-art laboratory services and products with clients in the healthcare, clinical, life science research and biopharma industries, with a focus on improving patient diagnosis, management and care. Group revenues are derived from four core businesses areas:
• Infectious Disease Testing – a range of COVID-19 testing services for commercial enterprises, private healthcare groups, NHS and the DHSC. Utilising multiple technologies, including lateral flow testing solutions, SourceBio offers screening, gold standard RT-PCR and whole genome sequencing COVID-19 testing solutions and operates under ISO 15189 accreditation required by the DHSC. SourceBio also provides employee testing solutions to industry, and direct to consumer home test kits (including ”Fit to Fly”, ”Test to Release” and ”2 & 8 Day International Travel” approved tests).
• Healthcare Diagnostics – histopathology cancer screening and clinical diagnostic services for the NHS and private healthcare across the UK and Ireland.
• Genomics – DNA sequencing services for pharmaceutical and biotechnology companies, academia, contract research organisations (CROs) and other research groups in the UK, Europe and North America.
• Stability Storage – shelf-life testing services and equipment for pharmaceutical and biotechnology companies, contract manufacturers and analytical testing companies from around the world but primarily in the UK, Ireland and the USA.
More details on Group operations can be found here: www.sourcebioscience.com.
SourceBio International plc (SBI) is listed on the AIM market of the London Stock Exchange.
